Case Study: Pfizer achieves production-ready HTS automation with HighRes

Pfizer commissions 3 HTS automation systems in one year with HighRes

The customer, Pfizer, faced the challenge of rapidly building and equipping a new high-throughput screening (HTS) facility to support its early drug discovery portfolio. Key requirements included integrating legacy equipment, achieving full environmental health and safety (EH&S) compliance, and ensuring built-in flexibility and redundancy for their new automation systems. They partnered with the vendor, HighRes, to design and implement these production-ready solutions.

HighRes implemented three major Nucleus® automation systems for Pfizer within a single year. The solution included the ZCell, Tri-Doc, and ACell Rail systems, which integrated both new and legacy instruments and provided compliant, HEPA-enclosed environments for cell-based work. The results were three production-ready HTS systems commissioned in a newly renovated lab, enabling near-immediate production screening and providing fully automated, parallel cell-based and biochemical assay capabilities.

Pfizer